JPH05301838A
(en)
*
|
1991-10-15 |
1993-11-16 |
Mitsubishi Kasei Corp |
Styrene derivative
|
GB9212673D0
(en)
*
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
GB9222253D0
(en)
*
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
GB9226830D0
(en)
*
|
1992-12-23 |
1993-02-17 |
Celltech Ltd |
Chemical compounds
|
US5622977A
(en)
*
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
GB9304919D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
JPH09500125A
(en)
*
|
1993-07-15 |
1997-01-07 |
キャンサー リサーチ キャンペーン テクノロジー リミテッド |
Prodrugs of protein tyrosine kinase inhibitors
|
IL107736A
(en)
*
|
1993-11-24 |
2001-01-11 |
Yissum Res Dev Co |
Pharmaceutical composition for the prevention of septic shock and for the treatment of chronic inflammatory diseases
|
ATE260911T1
(en)
*
|
1993-12-22 |
2004-03-15 |
Celltech R&D Ltd |
TRISUBSUTITUTED PHENYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PHOSPHODIESTERASE (TYPE IV) INHIBITORS
|
GB9326173D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
US5519042A
(en)
*
|
1994-01-13 |
1996-05-21 |
Hoechst Aktiengesellschaft |
Method of treating hyperproliferative vascular disease
|
WO1995024190A2
(en)
*
|
1994-03-07 |
1995-09-14 |
Sugen, Inc. |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
GB9405046D0
(en)
*
|
1994-03-15 |
1994-04-27 |
Unilever Plc |
Skin treatment composition
|
US5786354A
(en)
*
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412672D0
(en)
*
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526246D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526245D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9608435D0
(en)
*
|
1996-04-24 |
1996-06-26 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9619284D0
(en)
*
|
1996-09-16 |
1996-10-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9622363D0
(en)
*
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
*
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
JP2001507349A
(en)
|
1996-12-23 |
2001-06-05 |
セルテック セラピューティックス リミテッド |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6420338B1
(en)
*
|
1997-06-13 |
2002-07-16 |
New York University Medical Center |
Inhibition of the Src kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma
|
GB9713087D0
(en)
*
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
CA2288854C
(en)
|
1998-11-11 |
2009-09-15 |
F. Hoffmann-La Roche Ag |
Novel indanylidene compounds
|
EP1000950B1
(en)
*
|
1998-11-11 |
2004-02-25 |
F. Hoffmann-La Roche Ag |
Novel indanylidene compounds
|
GB9914258D0
(en)
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
MXPA03010810A
(en)
|
2001-05-29 |
2004-03-22 |
Schering Ag |
Cdk inhibiting pyrimidines, production thereof and their use as medicaments.
|
DE102004039373A1
(en)
*
|
2004-08-12 |
2006-02-23 |
Grünenthal GmbH |
Para-alkyl-substituted N- (4-hydroxy-3-methoxy-benzyl) -cinnamic acid amides and their use for the preparation of medicaments
|
WO2011080736A1
(en)
|
2009-12-29 |
2011-07-07 |
Mapi Pharma Hk Limited |
Intermediate compounds and processes for the preparation of tapentadol and related compounds
|